Prosight Management »

Nektar Therapeutics shares owned by Prosight Management

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Prosight Management from 13F filings

Historical chart of Prosight Management investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Prosight Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Prosight Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $23M 555k 42.28

More positions owned by Prosight Management

Procept Biorobotics Corp (PRCT)
Galapagos Nv Spon Adr (GLPG)
Janux Therapeutics (JANX)
Adc Therapeutics Sa SHS (ADCT)
Kura Oncology (KURA)
Meiragtx Holdings (MGTX)
Nektar Therapeutics Com New (NKTR)
Veeva Sys Cl A Com (VEEV)
Icon SHS (ICLR)
Boston Scientific Corporation (BSX)
Concentra Group Holdings Par Common Stock (CON)
Phreesia (PHR)
Amicus Therapeutics (FOLD)
Select Medical Holdings Corporation (SEM)
Syndax Pharmaceuticals (SNDX)

View all positions for Prosight Management

Top funds holding Nektar Therapeutics

BVF
Susquehanna International
Vanguard Group
Citadel Advisors
BlackRock
Millennium Management
Prosight Management
Invesco
Point72 Asset Management
Sofinnova Ventures
Two Sigma Investments
Emerald Advisers
22NW
Qube Research & Technologies
Voloridge Investment Management

View all funds holding Nektar Therapeutics